September 14, 2020
This page collects in one place scientific literature regarding the CANS-MCI referred to in our other science-related blog posts. The purpose of this post is to give you quick access to published literature so you may download them in one place.
May 30, 2019
In further analysis from a multi-year study of 81 adults conducted by the Kentucky Neuroscience Institute, the CANS-MCI has been as shown to be predictively sensitive to heightened CSF levels of Aβ and tau. All test dimension of the CANS-MCI help determine the chances of progression to Alzheimer’s even in the earliest, preclinical stages of the disease, despite the fact that individuals still perform within healthy ranges.
August 1, 2018
In a multi-year study of 81 adults conducted by the Kentucky Neuroscience Institute, the CANS-MCI has been shown to be sensitive to heightened CSF levels of Aβ and tau. CANS-MCI measures of the onset and speed of cognitive decline can help determine the need for further, expensive biomarker screening.
December 7, 2017
The CANS-MCI was developed to solve a problem: there were no tools available that could accurately and economically detect the cognitive changes most predictive of further abnormal decline in adults and the elderly. The most common type of decline in need of early detection was toward Alzheimer’s disease. Therefore the CANS-MCI was based upon a wide array of previous research concerning the changes most predictive of Alzheimer’s.
November 22, 2017
Although the Internet may appear to give the advantage of availability and ease of access — especially to physically disabled people — the reliability of Internet test results is markedly affected by two detrimental human factors: distractions and coaching. Computer-administered tests should be given by a neutral tester in a controlled environment, preferably a designated quiet room in a medical facility.